bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.07.07.548062

A growth chart of brain function from infancy to adolescence based on electroencephalography

Abstract

BackgroundIn children, objective, quantitative tools that determine functional neurodevelopment are scarce and rarely scalable for clinical use. Direct recordings of cortical activity using routinely acquired electroencephalography (EEG) offer reliable measures of brain function. MethodsWe developed and validated a measure of functional brain age (FBA) using a residual neural network-based interpretation of the paediatric EEG. In this cross-sectional study, we included 1056 children with typical development ranging in age from 1 month to 18 years. We analyzed a 10 to 15 minute segment of 18-channel EEG recorded during light sleep (N1 and N2 states). FindingsThe FBA obtained from EEG had a weighted mean absolute error (wMAE) of 0.85 years (95%CI: 0.69-1.02; n = 1056). A two-channel version of the FBA had a wMAE of 1.51 years (95%CI: 1.30-1.73; n = 1056) and was validated on an independent set of EEG recordings (wMAE = 2.27 years, 95%CI: 1.90-2.65; n = 723). Group-level maturational delays were also detected in a small cohort of children with Trisomy 21 (Cohens d = 0.36, p = 0.028). InterpretationAn FBA, based on EEG, is an accurate, practical and scalable automated tool to track brain function maturation throughout childhood with accuracy comparable to widely used physical growth charts. FundingThis research was supported by the National Health and Medical Research Council, Australia, Helsinki University Diagnostic Center Research Funds, Finnish Academy, Finnish Paediatric Foundation, and Sigrid Juselius Foundation. RESEARCH IN CONTEXTO_ST_ABSEvidence before this studyC_ST_ABSTools for objectively tracking neurodevelopment in paediatric populations using direct measurement of the brain are rare. Prior to conducting this study, we explored multiple databases (Google Scholar, PubMed, Web of Science) with search strategies that combined one or more of the terms "paediatric brain development", "brain age", "age estimation", "MRI measurements", "EEG measurements", "machine learning", "artificial intelligence", "advanced ageing", "neurodevelopmental delays" and "growth charts" with no restrictions on language and dates. In screening over 500 publications, 7 studies evaluated brain age in children using MRI and only a single study investigated maturation in EEG activity across discrete age bins. Added value of this studyWe formulated a measure of functional brain age (FBA) using state-of-the-art machine learning (ML) algorithms trained on a large, unique database consisting of multichannel clinical EEG recorded from N1/N2 sleep (n = 1056 children; 1 month to 17 years), with typical neurodevelopment confirmed at a 4-year follow-up. The FBA showed a high correlation with age and detected group-level differences associated with conditions of neurodevelopmental delay. Implications of all the available evidenceAge is prominent within EEG recordings of N1/N2 sleep and is readily extracted using ML. Public release of the FBA estimator and the use of EEG, commonly delivered in outpatient settings, as the basis of age prediction enables clear translation of measures of brain age to the clinic. Future work on EEG datasets across various neurodevelopmental profiles will enhance generalisability and user confidence in the clinical application of brain age.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Iyer, K. K., Roberts, J. A., Waak, M., Vogrin, S. J., Kevat, A., Chawla, J., Haataja, L. M., Lauronen, L., Vanhatalo, S., Stevenson, N. J.. 2023-07-07. A growth chart of brain function from infancy to adolescence based on electroencephalography. https://doi.org/10.1101/2023.07.07.548062

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗